Boston Scientific in €26m Clonmel investment

Boston Scientific is to invest €26m in research and development at its Clonmel facility, the company announced today.

The investment is supported by the Government through IDA Ireland and will enable Boston Scientific to significantly expand its R&D and technical capabilities related to the design of the company’s next-generation cardiac rhythm management devices manufactured at the Clonmel facility.